DK1724342T3 - Fremgangsmåde til fremstilling af Erysipelothrix rhusiopathiae overfladebeskyttende antigenmutant i Escherichia coli - Google Patents

Fremgangsmåde til fremstilling af Erysipelothrix rhusiopathiae overfladebeskyttende antigenmutant i Escherichia coli

Info

Publication number
DK1724342T3
DK1724342T3 DK05709866.7T DK05709866T DK1724342T3 DK 1724342 T3 DK1724342 T3 DK 1724342T3 DK 05709866 T DK05709866 T DK 05709866T DK 1724342 T3 DK1724342 T3 DK 1724342T3
Authority
DK
Denmark
Prior art keywords
spaa
erysipelothrix rhusiopathiae
surface protective
protective antigen
protein
Prior art date
Application number
DK05709866.7T
Other languages
English (en)
Inventor
Toshihiro Ushijima
Masashi Sakaguchi
Eiji Tokunaga
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of DK1724342T3 publication Critical patent/DK1724342T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK05709866.7T 2004-02-27 2005-02-08 Fremgangsmåde til fremstilling af Erysipelothrix rhusiopathiae overfladebeskyttende antigenmutant i Escherichia coli DK1724342T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004053882 2004-02-27
PCT/JP2005/001814 WO2005083072A1 (ja) 2004-02-27 2005-02-08 大腸菌における豚丹毒菌表層防御抗原変異体の製造方法

Publications (1)

Publication Number Publication Date
DK1724342T3 true DK1724342T3 (da) 2011-07-18

Family

ID=34908767

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05709866.7T DK1724342T3 (da) 2004-02-27 2005-02-08 Fremgangsmåde til fremstilling af Erysipelothrix rhusiopathiae overfladebeskyttende antigenmutant i Escherichia coli

Country Status (8)

Country Link
US (2) US8277820B2 (da)
EP (1) EP1724342B1 (da)
JP (1) JP4755977B2 (da)
CN (1) CN101031647B (da)
AT (1) ATE513909T1 (da)
DK (1) DK1724342T3 (da)
ES (1) ES2367128T3 (da)
WO (1) WO2005083072A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008054673A (ja) * 2006-08-03 2008-03-13 Hokkaido Univ 組み換え蛋白質の製造方法
JP2014000016A (ja) * 2012-06-15 2014-01-09 National Agriculture & Food Research Organization 豚丹毒菌の新規な抗原タンパク質、その遺伝子、及び組換えベクターとその利用
KR101535704B1 (ko) * 2012-12-28 2015-07-27 한국생명공학연구원 항원성 단백질 고정화를 통한 돈단독 백신 제조방법
CN103941002B (zh) * 2013-03-15 2016-03-16 河南省农业科学院 猪丹毒杆菌抗原快速检测试纸条
CN103397023B (zh) * 2013-08-20 2014-12-10 广东温氏食品集团股份有限公司 猪丹毒杆菌的pcr引物及其应用
CN106995489B (zh) * 2016-01-22 2018-11-06 华中农业大学 一种猪链球菌截短蛋白Sao及应用
TWI638827B (zh) 2017-07-25 2018-10-21 國立屏東科技大學 交叉保護性重組抗原及含彼之動物疫苗組成物
CN110183520B (zh) * 2019-05-25 2022-12-20 青岛易邦生物工程有限公司 一种猪丹毒SpaA蛋白及其在制备疫苗中的应用
CN113388624A (zh) * 2020-09-21 2021-09-14 浙江理工大学 一种猪丹毒SpaA抗原蛋白及其优化克隆的制备方法
CN116284274A (zh) * 2022-12-13 2023-06-23 中国兽医药品监察所 一种重组猪丹毒杆菌表面抗原SpaA蛋白及其应用
CN115850404B (zh) * 2022-12-13 2024-02-09 中国兽医药品监察所 一种串联优势表位的重组猪丹毒杆菌表面保护抗原a及其应用
CN119220501A (zh) * 2024-10-15 2024-12-31 中国兽医药品监察所 一株分泌抗猪丹毒丝菌SpaA蛋白的细胞株及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1040923A (zh) * 1989-06-08 1990-04-04 易超伦 血清组合物及其配制方法
JPH0630771A (ja) * 1992-07-14 1994-02-08 Ajinomoto Co Inc バクテリアルトランスグルタミナーゼの製造法及び関連物
AU3364000A (en) * 1999-02-10 2000-08-29 Rockefeller University, The Antigen of erysipelothirx rhusiopathiae comprising an immuno-protective epitope
JP3072345B1 (ja) 1999-03-31 2000-07-31 農林水産省家畜衛生試験場長 豚丹毒菌の組換えサブユニットワクチン
CN1281731A (zh) * 1999-07-22 2001-01-31 李六金 猪用免疫球蛋白注射液
JP3532510B2 (ja) * 2000-07-21 2004-05-31 独立行政法人農業・生物系特定産業技術研究機構 組換え豚丹毒菌防御抗原の回収精製法
JP2002306163A (ja) * 2001-04-11 2002-10-22 Chemo Sero Therapeut Res Inst 大腸菌を宿主とする遺伝子組換えヒトトロンビンの調製方法

Also Published As

Publication number Publication date
EP1724342B1 (en) 2011-06-22
US20110059021A1 (en) 2011-03-10
JPWO2005083072A1 (ja) 2007-11-22
CN101031647B (zh) 2010-12-29
US8277820B2 (en) 2012-10-02
WO2005083072A1 (ja) 2005-09-09
CN101031647A (zh) 2007-09-05
ES2367128T3 (es) 2011-10-28
US20080286309A1 (en) 2008-11-20
EP1724342A4 (en) 2008-08-13
US8361749B2 (en) 2013-01-29
ATE513909T1 (de) 2011-07-15
EP1724342A1 (en) 2006-11-22
JP4755977B2 (ja) 2011-08-24

Similar Documents

Publication Publication Date Title
DK1373301T3 (da) Reducering af immunogeniciteten af fusionsproteiner
DK1185691T3 (da) Genomiske neisseriasekvenser og fremgangmåder til anvendelse deraf
NL300899I2 (nl) Neisseira meningitidis serogroep B recombinant gelipideerd fHbp subfamilie A05 eiwit en Neisseira meningitidis serogroep B recombinant gelipideerd fHbp subfamilie B01 eiwit
EP1548032A4 (en) KDR-PEPTIDES AND VACCINES CONTAINING THEM
WO2003080114A3 (en) Imidazoquinoline adjuvants for vaccines
WO2006068663A3 (en) Vaccine compositions for treating coronavirus infection
EP1724342A4 (en) PROCESS FOR PREPARING AN ERYSIPELOTHRIX RHUSIOPATHIAE SURFACE PROTECTIVE ANTIGENMUTANTE IN ESCHERICHIA COLI
DE69940775D1 (de) Peptidzusammensetzung als immunogen zur allergiebehandlung.
BRPI1015917A2 (pt) antígenos de rsv recombinantes.
MXPA01003557A (es) Secuencias genomicas de neisseria y metodos para su uso.
DK1349944T3 (da) Latensassocieret peptid af TGF-beta til at bibringe farmaceutisk aktive proteiner latens
WO2006090385A3 (en) Protease inhibitors and method of screening thereof
DE602004001727D1 (de) Verfahren zur herstellung cyclischer peptide
DK2229440T3 (da) Rekombinante elastase-proteiner og fremgangsmåder til fremstilling og anvendelse deraf
ATE469170T1 (de) Zusammensetzungen und verfahren mit dem respiratory syncytial virus untergruppe b stamm 9320
EE200500012A (et) Peptiid-pähine passiivne immunoteraapia ateroskleroosi raviks
DE60316189D1 (de) P153- und p156-antigene zur immundiagnose von ehrlichiose in hunden und menschen und verwendungen davon
DK2289533T3 (da) Epitoppeptider afledt af karendothelvækstfaktorreceptor-1 samt vacciner indeholdende disse peptider
PT1962889E (pt) Polipéptido imunogénico formado por péptidos crípticos optimizados provenientes de antigénios tumorais, e suas utilizações
DE69922804D1 (de) Verwendung von polymeren der hyaluronsäure zur mukosalen freigabe von impfstoffen und adjuvantien
MX2024005962A (es) Composiciones de proteínas de fusión inmunogénicas y métodos de uso de estas
WO2006113782A3 (en) Lawsonia protein useful as a component in subunit vaccine and methods of making and using thereof
WO2004074491A3 (en) Expression in plants of antibodies against enterotoxigenic escherichia coli
WO2009083968A8 (en) Novel protein
WO2007101948A3 (fr) Nouveaux vaccins destines au traitement ou a la prevention des infections par parasites de la famille des taenidae et en particulier du genre echinococcus